- IN₹144.17bn
- IN₹130.70bn
- IN₹35.11bn
Brief: Indegene Says U.S. Court Preliminarily Approves Proposed Class Action Settlement On Aug 27, 2026
Brief: Indegene Authorizes Execution Of Settlement Agreement In TCPA Class Action Lawsuit
Brief: Indegene June-Quarter Consol Net Profit 1.16 Billion Rupees
Brief: Indegene Posts March-Qtr Consol Profit 797 Million Rupees
Brief: Indegene Ltd Says Unit Signs Agreement To Buy Business And Assets Of Trilogy Writing And Consulting Ltd
Brief: Indegene Dec-Quarter Consol Net Profit 1.03 Billion Rupees
Brief: Indegene Subsidiaries Amalgamate To Form Indegene Healthcare Canada Inc
Brief: Indegene Sept-Quarter Consol Net Profit 1.02 Billion Rupees
Brief: Indegene And Datavant Partner To Enhance Clinical Trial Recruitment
India's Indegene up as ICICI Securities begins coverage with bullish outlook
Brief: Indegene Expands Presence In India With Opening Of New Center In Pune
India's Indegene gains on quarterly profit rise
Brief: Indegene June-Quarter Consol Net Profit 1.16 Billion Rupees
Brief: Indegene Ltd Launches NEXT Medical Writing Automation
India's Indegene falls after block deals at discount
Brief: Indegene Dividend Of 2 Rupees Per Share
Brief: Indegene Announces Launch Of A New Center In London
Brief: Indegene Expands Footprint In Europe, Launches New Entity In Spain
Brief: Indegene Dec-Quarter Consol Net Profit 1.10 Bln Rupees